NBT Bank’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$283K Sell
537
-12
-2% -$6.73K 0.02% 327
2026
Q1
$308K Sell
549
-682
-55% -$437K 0.02% 327
2025
Q4
$383K Buy
1,231
+38
+3% +$25.9K 0.02% 301
2025
Q3
$362K Buy
1,193
+618
+107% +$375K 0.02% 309
2025
Q2
$308K Hold
575
0.02% 321
2025
Q1
$241K Buy
575
+13
+2% +$5.64K 0.02% 347
2024
Q4
$232K Buy
562
+550
+4,583% +$241K 0.02% 354
2024
Q3
$6.06K Hold
12
﹤0.01% 726
2024
Q2
$5.85K Hold
12
﹤0.01% 499
2024
Q1
$6.48K Hold
12
﹤0.01% 497
2023
Q4
$6.66K Buy
+12
New +$5.63K ﹤0.01% 490

Other funds holding IDXX

NBT Bank's IDXX Position: Q2 2026 in Review

NBT Bank reduced its Idexx Laboratories (IDXX) stake by 2.2% in Q2 2026, selling an estimated $6.73K and leaving 537 shares worth $283K. The position accounts for 0.02% of the portfolio, ranked #327.

NBT Bank first reported a position in IDXX in Q4 2023 and has held it in 11 quarters since. The position peaked at $383K in Q4 2025. 1,305 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • NBT Bank held 537 shares of Idexx Laboratories worth $283K as of Q2 2026.
  • NBT Bank sold 12 Idexx Laboratories shares in Q2 2026, an estimated $6.73K.
  • Idexx Laboratories made up 0.02% of NBT Bank's portfolio in Q2 2026, its #327 holding.
  • NBT Bank first reported a position in Idexx Laboratories in Q4 2023 and has held it in 11 quarters since.
  • NBT Bank's Idexx Laboratories position peaked at $383K in Q4 2025.
  • 1,305 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on NBT Bank's 13F filing for Q2 2026, filed 29 Jul 2026.